logo

DCTH

Delcath Systems·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

DCTH fundamentals

Delcath Systems (DCTH) released its earnings on Nov 4, 2025: revenue was 20.60M (YoY +83.93%), missed estimates; EPS was 0.02 (YoY -66.67%), beat estimates.
Revenue / YoY
20.60M
+83.93%
EPS / YoY
0.02
-66.67%
Report date
Nov 4, 2025
DCTH Earnings Call Summary for Q3,2025
  • Revenue Growth: HEPZATO volume up 150% YoY, CHOPAT trial data driving 76% ORR
  • Site Expansion: 25 active sites → 60+ by 2026
  • Financial Strength: $89M cash, 87% gross margin
  • Competitive Risk: 109-patient Thomas Jefferson trial competition
  • Pipeline: CRC trial interim data Q2 2027, breast cancer trial enrollment Q1 2026
EPS
Revenue

Revenue & Expenses

DCTH has released its 2025 Q3 earnings report, with revenue of 20.56M, reflecting a YoY change of 83.60%, and net profit of 830.00K, showing a YoY change of -55.47%. The Sankey diagram below clearly presents DCTH's revenue sources and cost distribution.

Key Indicators

Delcath Systems (DCTH) key financial stats and ratios, covering profitability, financial health, and leverage.
Delcath Systems (DCTH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Delcath Systems (DCTH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Delcath Systems (DCTH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Delcath Systems (DCTH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Delcath Systems (DCTH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield